Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from EUDA Health Holdings ( (EUDA) ).
On April 23, 2026, EUDA Health Holdings received notice from Nasdaq that its market value of listed securities had fallen below the required $35 million minimum for 32 consecutive business days, breaching Listing Rule 5550(b)(2). The notification, disclosed on April 27, 2026, does not immediately affect the stock’s listing, but the company now faces a 180-day window, until October 20, 2026, to restore its market value to at least $35 million for ten straight trading days or risk potential delisting and a subsequent appeal process that offers no assurance of success for shareholders.
The compliance deadline increases near-term uncertainty around EUDA’s status on the Nasdaq Capital Market and underscores ongoing pressure on its market valuation. While trading continues as normal for now, the prospect of delisting if the company cannot regain compliance could impact liquidity, investor confidence, and EUDA’s visibility in U.S. capital markets.
The most recent analyst rating on (EUDA) stock is a Buy with a $2.75 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based healthcare company whose shares trade on the Nasdaq Capital Market in the U.S. It operates in the digital and technology-enabled health sector, giving investors exposure to Asia-focused healthcare services through a U.S.-listed equity vehicle.
Average Trading Volume: 90,005
Technical Sentiment Signal: Sell
Current Market Cap: $26.71M
Find detailed analytics on EUDA stock on TipRanks’ Stock Analysis page.